Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1634

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodary, P. F.
Right arrow Articles by Eitzman, D. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bodary, P. F.
Right arrow Articles by Eitzman, D. T.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Genetically altered mice
Right arrow Smooth muscle proliferation and differentiation
Right arrow Arterial thrombosis
Right arrow Type 2 diabetes
Right arrow Risk Factors for Stroke
Right arrow Platelets
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1634.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient Mice

Peter F. Bodary; Shufang Gu; Yuechun Shen; Alyssa H. Hasty; Joshua M. Buckler; Daniel T. Eitzman
Objective— The direct role of leptin in vascular disease remains controversial. The objective of this study was to examine the effects of leptin treatment on atherosclerosis and thrombosis in atherosclerotic-prone mice.

Methods and Results— Sixteen-week-old, male apolipoprotein E–deficient mice were treated with injections of recombinant leptin (125 µg per day IP; n=10) or vehicle (n=10) for 4 weeks. Leptin treatment resulted in reduced epididymal fat (352±30.7 versus 621±61.5 mg; P=0.005) and fasting insulin (0.57±0.25 versus 1.7±0.22 ng/mL; P=0.014). Despite these metabolic benefits, leptin treatment resulted in an increase in atherosclerosis (8.0±0.95% versus 5.4±0.59% lesion surface coverage; P<0.05). Leptin treatment also resulted in a shortened time to occlusive thrombosis after vascular injury (21±2.1 versus 34.6±5.4 minutes; P=0.045).

Conclusions— These studies indicate that exogenous leptin promotes atherosclerosis and thrombosis and support the concept that elevations of leptin may increase the risk for cardiovascular disease.


Key Words: obesity • vascular smooth muscle • arterial injury • adipocyte • adipokines




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. F. Bodary, Y. Shen, M. Ohman, K. L. Bahrou, F. B. Vargas, S. S. Cudney, K. J. Wickenheiser, M. G. Myers Jr, and D. T. Eitzman
Leptin Regulates Neointima Formation After Arterial Injury Through Mechanisms Independent of Blood Pressure and the Leptin Receptor/STAT3 Signaling Pathways Involved in Energy Balance
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 70 - 76.
[Abstract] [Full Text] [PDF]